Michel Kranendonk

10PUBLICATIONS
19CO-AUTHORS
Metabolic medicineCancer therapy (excl. chemotherapy and radiation therapy)Nanoscale characterisationCharacterisation of biological macromoleculesOptical properties of materials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 20, 2026
Deciphering cytochrome P450 reductase role in MASLD: molecular mechanisms and pathophysiological implications.

|Feb 25, 2025
The Adaptation of MCF-7 Breast Cancer Spheroids to the Chemotherapeutic Doxorubicin: The Dynamic Role of Phase I Drug Metabolizing Enzymes.

Daniel Crispim, Carolina Ramos, Francisco Esteves

|Jun 19, 2024
Challenges of the Application of In Vitro Digestion for Nanomaterials Safety Assessment.

Nádia Vital, Ana Catarina Gramacho, Mafalda Silva

|May 28, 2024
Pleiotropy of Progesterone Receptor Membrane Component 1 in Modulation of Cytochrome P450 Activity.

Isabel S Barata, José Rueff, Michel Kranendonk

|Jul 29, 2023
Single Mutations in Cytochrome P450 Oxidoreductase Can Alter the Specificity of Human Cytochrome P450 1A2-Mediated Caffeine Metabolism.

Francisco Esteves, Cristina M M Almeida, Sofia Silva

|Nov 11, 2022
The Complex Dynamic of Phase I Drug Metabolism in the Early Stages of Doxorubicin Resistance in Breast Cancer Cells.

Isabel S Barata, Bruno C Gomes, António S Rodrigues

Pageof 2

Frequent Collaborators

7 joint publications

Francisco Esteves

3 joint publications

José Rueff

3 joint publications

Philippe Urban

2 joint publications

Gilles Truan